Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.
Bonito Biosciences has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Bonito Biosciences's investors include Lightstone Ventures, Anterra Capital, Jazz Venture Partners.
Bonito Biosciences is headquartered in Waltham, United States.
Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.
Bonito Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bonito Biosciences — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/bonito-biosciences. Accessed September 30, 2026.
VCBacked. (2024). Bonito Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bonito-biosciences
{{cite web |title=Bonito Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bonito-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated